07/16/2025
Celebrating a medical milestone in Indiana! 🎉
The team at Community Heart and Vascular Hospital has successfully performed the first commercial transcatheter tricuspid valve replacement (TTVR) in the state using the FDA-approved EVOQUE™ system from Edwards Lifesciences. This groundbreaking, minimally invasive procedure offers new hope for patients with severe tricuspid regurgitation—restoring valve function in about an hour, with faster recovery and improved quality of life.
💡 EVOQUE is the world’s first and only FDA-approved transcatheter tricuspid valve replacement system, with clinical trials showing over 95% success in reducing TR to mild or less within a year.
👏 Hats off to our expert team for leading the way in structural heart care innovation.
🫀 “This new technology gives our physicians another vital tool to treat valvular heart disease—without open-heart surgery,” said Dr. Sandeep Dube.